Beta
ManageSearchChatDiscover
329605

Intraoperative infusion of lidocaine 2% reduces postoperative fentanyl requirements for pain control in renal transplantation surgery

Article

Last updated: 29 Dec 2024

OverviewSimilar Items

Subjects

-

Tags

-

Abstract

Background
Intravenous lidocaine has been shown to be an analgesic and anti-inflammatory medication with modulation of excessive inflammatory response.
Results
Our study detected increased fentanyl consumption in the recovery for the fentanyl group more than the lidocaine group. The request of the first dose of analgesic was significantly longer in lidocaine group than in fentanyl group.
Conclusion
The usage of intraoperative lidocaine infusion decreased postoperative fentanyl requirements as analgesic in patients undergoing renal transplantation.
Trial registration
Registration on ANZCTR number , REGISTERED 08 August 2018.

DOI

10.1186/s42077-020-00106-6

Keywords

Lidocaine 2% infusion, Fentanyl, Postoperative Pain, Anesthesia for renal transplantation

Authors

First Name

Mostafa K.

Last Name

Abdellatif

MiddleName

-

Affiliation

-

Email

mostafa_2041980@yahoo.com

City

-

Orcid

0000-0002-5473-8014

First Name

Tamer H.

Last Name

Ibrahim

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

Volume

12

Article Issue

1

Related Issue

44737

Issue Date

2020-01-01

Receive Date

2020-10-15

Publish Date

2020-11-02

Print ISSN

1687-7934

Online ISSN

2090-925X

Article File

ASJA3296051604268000.pdf

PDF . 451.9kB

Link

https://asja.journals.ekb.eg/article_329605.html

Detail API

https://asja.journals.ekb.eg/service?article_code=329605

Order

329,605

Publication Type

Journal

Publication Title

Ain-Shams Journal of Anesthesiology

Publication Link

https://asja.journals.ekb.eg/

MainTitle

Intraoperative infusion of lidocaine 2% reduces postoperative fentanyl requirements for pain control in renal transplantation surgery

Details

Type

Article

Created At

20 Dec 2024